Holen Sie sich die Stockscreener-App
11.16
0.36%
-0.065
Schlusskurs vom Vortag:
$11.23
Offen:
$11.14
24-Stunden-Volumen:
23,021
Relative Volume:
0.04
Marktkapitalisierung:
$768.33M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-209.96M
KGV:
-3.7593
EPS:
-2.97
Netto-Cashflow:
$-176.27M
1W Leistung:
-1.84%
1M Leistung:
-1.41%
6M Leistung:
+100.90%
1J Leistung:
+7.29%
1-Tages-Spanne:
$11.13
$11.35
1-Wochen-Bereich:
$10.57
$11.50
52-Wochen-Spanne:
$4.92
$12.97
Replimune Group Inc Stock (REPL) Company Profile
Firmenname
Replimune Group Inc
Sektor
Branche
Telefon
(781) 222-9600
Adresse
500 UNICORN PARK, WOBURN, MA
Vergleichen Sie REPL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| REPL | 11.20 | 768.33M | 0 | -209.96M | -176.27M | -2.97 |
| VRTX | 446.39 | 115.74B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 739.76 | 81.65B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 584.60 | 34.86B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 248.09 | 32.09B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 102.30 | 24.49B | 3.30B | -501.07M | 1.03B | 11.54 |
Replimune Group Inc Stock (REPL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-17 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-11-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | BTIG Research | Buy |
| 2020-11-17 | Eingeleitet | BTIG Research | Buy |
| 2020-11-02 | Eingeleitet | Jefferies | Buy |
| 2020-10-15 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2020-07-01 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2020-05-05 | Eingeleitet | Barclays | Overweight |
| 2019-09-04 | Eingeleitet | ROTH Capital | Buy |
| 2019-07-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2019-07-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2019-07-08 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-04-25 | Eingeleitet | Wedbush | Outperform |
| 2019-01-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2018-08-14 | Eingeleitet | JP Morgan | Overweight |
| 2018-08-14 | Eingeleitet | Leerink Partners | Outperform |
Alle ansehen
Replimune Group Inc Aktie (REPL) Neueste Nachrichten
Replimune's chief commercial officer sells $56,131 in stock By Investing.com - Investing.com Nigeria
Replimune group's chief medical officer sells shares worth $78,111 By Investing.com - Investing.com Canada
Replimune's chief commercial officer sells $56,131 in stock - Investing.com
REPL (Replimune Group) Peter Lynch Fair Value : N/A (As of Nov. 20, 2024) - GuruFocus.com
Replimune Group, Inc. (NASDAQ:REPL) Shares Acquired by LMR Partners LLP - MarketBeat
Replimune Group Q3 EPS Forecast Decreased by Leerink Partnrs - Defense World
What is Wedbush's Estimate for Replimune Group Q3 Earnings? - MarketBeat
HC Wainwright Predicts Stronger Earnings for Replimune Group - MarketBeat
Leerink Partnrs Weighs in on Replimune Group Q3 Earnings - MarketBeat
Significant Stake Increase by Baker Bros. Advisors in Replimune Group Inc - GuruFocus.com
Brokerages Set Replimune Group, Inc. (NASDAQ:REPL) Target Price at $16.80 - Defense World
When (REPL) Moves Investors should Listen - Stock Traders Daily
Replimune Group’s Q3 2024 Financial Highlights - TipRanks
Replimune Group Inc. (REPL) Quarterly 10-Q Report - Quartzy
Replimune Group (NASDAQ:REPL) Receives Buy Rating from HC Wainwright - MarketBeat
Replimune Reports $432.1M Cash Position, Advances Melanoma Treatment BLA Plans | REPL Stock News - StockTitan
Replimune stock soars to 52-week high, touches $12.86 By Investing.com - Investing.com Australia
Analysts Set Replimune Group, Inc. (NASDAQ:REPL) Price Target at $16.80 - MarketBeat
Replimune stock soars to 52-week high, touches $12.86 - Investing.com India
Replimune Group (NASDAQ:REPL) Hits New 52-Week HighStill a Buy? - MarketBeat
Creative Planning Buys 4,699 Shares of Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune's RP1 Shows 33.6% Response Rate in Melanoma Trial, Marks Breakthrough | REPL Stock News - StockTitan
Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Replimune Group Awards Stock Options, RSUs to New Employees in Retention Move | REPL Stock News - StockTitan
TSX Consumer Staples Capped Index (TTCS) QuotePress Release - The Globe and Mail
KBW Bank Index (BKX) QuotePress Release - The Globe and Mail
Itron Inc (ITRI-Q) QuotePress Release - The Globe and Mail
Vanguard Group's Strategic Acquisition in Replimune Group Inc - GuruFocus.com
Teledyne Technologies Inc (TDY-N) QuotePress Release - The Globe and Mail
Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - The Manila Times
Masco Corp (MAS-N) QuotePress Release - The Globe and Mail
Skechers U.S.A. (SKX-N) QuotePress Release - The Globe and Mail
S&P GSCI Index (GNX) QuotePress Release - The Globe and Mail
Non-melanoma Skin Cancer is Predicted to Exhibit Remarkable Growth During the Study Period (2020–2034) | DelveInsight - GlobeNewswire Inc.
SG Americas Securities LLC Invests $251,000 in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Given Average Recommendation of "Buy" by Analysts - MarketBeat
It would be worthwhile to take a closer look at Replimune Group Inc (REPL) - US Post News
Daily Progress: Replimune Group Inc (REPL) Drop -7.06, Closing at 10.67 - The Dwinnex
Replimune Group Inc [REPL] Insider Selling: Time to sell? - Knox Daily
Replimune Group Inc Inc. (REPL) Price Performance: A Comparative Analysis with Competitors - The InvestChronicle
Replimune Group (NASDAQ:REPL) Stock Price Down 5.2%Here's What Happened - MarketBeat
Learn to Evaluate (REPL) using the Charts - Stock Traders Daily
Cubist Systematic Strategies LLC Buys 53,313 Shares of Replimune Group, Inc. (NASDAQ:REPL) - MarketBeat
Gaining Ground: Replimune Group Inc (REPL) Closes Higher at 11.74, Up 3.62 - The Dwinnex
Investing in Replimune Group Inc (REPL) Is Getting More Attractive - Knox Daily
Replimune Group, Inc. (NASDAQ:REPL) Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Morgan Stanley's Strategic Reduction in Replimune Group Inc Holdings - GuruFocus.com
Cubist Systematic Strategies LLC Increases Position in Replimune Group, Inc. (NASDAQ:REPL) - Defense World
Replimune Group, Inc. (NASDAQ:REPL) Shares Purchased by Millennium Management LLC - MarketBeat
Chief Financial Officer Hill Emily Luisa sale 8,938 shares of Replimune Group Inc [REPL] - Knox Daily
Insiders At Replimune Group Sold US$863k In Stock, Alluding To Potential Weakness - Simply Wall St
Finanzdaten der Replimune Group Inc-Aktie (REPL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Replimune Group Inc-Aktie (REPL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Sarchi Christopher | Chief Commercial Officer |
Nov 18 '24 |
Sale |
10.78 |
5,207 |
56,131 |
87,045 |
| Hill Emily Luisa | Chief Financial Officer |
Aug 16 '24 |
Sale |
10.18 |
8,938 |
90,989 |
101,057 |
| Xynos Konstantinos | Chief Medical Officer |
Jun 07 '24 |
Sale |
7.50 |
15,881 |
119,108 |
117,131 |
| Sarchi Christopher | Chief Commercial Officer |
May 16 '24 |
Sale |
6.47 |
2,218 |
14,350 |
92,252 |
| Schwendenman Andrew | Chief Accounting Officer |
May 16 '24 |
Sale |
6.47 |
2,298 |
14,868 |
38,238 |
| Love Colin | Chief Operating Officer |
May 16 '24 |
Sale |
6.47 |
17,615 |
113,969 |
777,345 |
| Astley-Sparke Philip | Executive Chairman |
May 16 '24 |
Sale |
6.47 |
37,928 |
245,394 |
1,487,350 |
| Coffin Robert | Director |
May 16 '24 |
Sale |
6.47 |
11,464 |
74,172 |
1,821,872 |
| Patel Sushil | Chief Executive Officer |
May 16 '24 |
Sale |
6.47 |
20,194 |
130,655 |
212,014 |
| Xynos Konstantinos | Chief Medical Officer |
May 16 '24 |
Sale |
6.47 |
6,367 |
41,194 |
133,012 |
0.42%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):